The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
In 2024, healthcare systems in the UK and worldwide faced the perfect storm of ageing, demand, and burnout. As we enter 2025, these trends are likely to persist.
Research has found that countries with higher success in minimising coronavirus cases and deaths, have more trust within their society and governments.
A Health Committee report finds that in the "most optimistic scenario" of increased treatment over the next three years, the NHS backlog could come down to pre-pandemic levels in 2025.
In Israel, healthcare professionals and those over 60 are now being encouraged to take the fourth booster dose - which appears to significantly increase waning third dose antibodies.
Unique “indicators” in the blood of patients with severe and fatal COVID could create simple diagnostic tests - to help doctors identify who could become critically ill.
According to data from two million people in Scotland and 42 million people in Brazil, AstraZeneca vaccine protection drops significantly three months after double-dosing.
Study finds older Black and Hispanic people are more likely to die prematurely due to exposure to air pollution, with race disparities in health costing $100 billion in the US.
Curtis R Youngs from Iowa State University probes the relationship between human and animal health in light of the COVID-19 pandemic, including comment on the food system & biosecurity programmes.
In a previous article, Lisa Riley, Vice President of Strategic Product and Partnership Development for VitalHub UK, cited how digital healthcare is helping to transform the NHS through whole system integration in planned care, here Stuart Jeffery talks from a customer perspective.
Claire Kendal-Wright, PhD, from Chaminade University of Honolulu, argues that when it comes to understanding the normal human parturition mechanisms, danger associated molecular patterns may be part of the answer.
Professor Sultan Mahmud, Director of Healthcare for BT’s Enterprise unit, discusses how BT is redefining its healthcare ambitions through co-creating NHS-first solutions with its vanguard partners.
